Quercetin is a natural compound that has many biological activities to treat various diseases especially as an antioxidant for cancer treatment. This research was conducted to prepare 99m Tc labeled quercetin as a potential cancer radiotracer. The 99m Tc-quercetin complex was prepared with varied parameters to find optimum labeling conditions. In this study, Tc. The reaction of complexation was quite rapid within a few minutes in room temperature. The radiochemical yield was confirmed by thin layer chromatography with labeling efficiency of 98.52 ± 0.96 %. These results would make 99m Tc-quercetin continue for following in vitro and in vivo studies to discover its effectiveness as an anticancer from a natural compound.
INTRODUCTION
During the last decade, interest in antioxidants compounds from the plant which can protect the body from several degenerative diseases has increased in the community. This recognition is based on the believed that the substance isolated from edible plants are supposed to be less toxic to the human body. Quercetin (3,3ʹ,4ʹ,5,7-pentahydroxyl-flavone) is a polyphenol flavonoid, categorized as a flavonol ( Fig.  1) , one of the major dietary flavonoids which are commonly present in various plants [1] [2] . The chemical structure of quercetin contains five hydroxyl groups which specify the biological activity of the flavonol compound. Antioxidant activity was due to the presence of double bonds between C2 and C3, as well as hydroxyl groups at positions C3 and C4'. Quercetin has importance purpose in pharmacology such as antioxidant [3] [4] [5] [6] [7] , neurological effects [8] [9] [10] , antiviral [11] [12] , anticancer [13] [14] , cardiovascular protection [15] [16] [17] , antimicrobial [18] [19] , anti-inflammatory [20] [21] , and hepatoprotective [22] [23] [24] . Several studies show that quercetin has a significant role in the inhibition of cancer cells in breast, ovary, prostate, colon, endometrium and lung 14, 25 , its inhibitory effect on tyrosine kinase was supposed for its antitumor therapeutic potentials 26 . Nuclear medicine is one of the medical fields which harnesses the nuclear properties of radioactive for diagnostic of anatomic/physiologic conditions of the human body; it also provides therapy with unsealed radioactive sources. Nuclear medicine requires radiopharmaceuticals/labeled compounds in the implementation of patient examination to obtain the results of imaging. A labeled compound can be described as a chemical substance which contains radioactive atoms within its structure and compatible with human administration to diagnose or treat diseases 27 . Quercetin is a chelating agent that able to build complexes with metals [28] [29] [30] . This ability as a chelator gives the chance of quercetin being labeled with a technetium-99m radioisotope ( 99m TcO4 -). Labeled compound of quercetin ( 99m Tc-quercetin) will interact with free radicals and help to recognize the accumulation of oxidative stress tissue. These free radicals and oxidative stress, both are the primary lead of cancer and other chronic diseases 31 .The prior paper presumed the molecular structure of 99m Tc-quercetin in Fig. 2 , though the details of the chemistry of molecular structure are not available yet 32 . Previously, a study of technetium-99m labeled quercetin has been done by Sayed et al in 2010 with the radiochemical purity of 99m Tc-quercetin > 99 %, but their study did not identify Tc-reduced ( 99m TcO2) as radiochemical impurities 28 . The objective of this study was to prepare a labeled compound of quercetin with technetium-99m. The reaction was conducted through the direct labeling method using tin(II) chloride (SnCl2) as reducing agent. Some parameters were observed to find the optimum labeling conditions including a number of quercetin, reaction pH, incubation time, and amount of reducing agent. This research was expected to obtain the optimum condition of 99m Tc-quercetin preparation which is proficient to be used for the in-vivo study; therefore the effectiveness of quercetin as an anticancer natural compound could be revealed. 
EXPERIMENTAL Materials
All of the chemicals in this research were used without any further purification. Quercetin hydrate and tin(II) chloride dehydrate were from Sigma-Aldrich. Acetone, sodium hydroxide, hydrochloric acid, pH indicator and TLC-SG F254 were purchased from Merck. Phosphate buffer pH 7.5 was produced in house. Tc/ 99 Mo generator to produce 99m TcO4 -was purchased from Polatom. Dose calibrator (Victoreen) and single channel analyzer (Ortec) were used to measured radioactivity.
Synthesis of 99m
Tc-Quercetin Labeling of quercetin with 99m Tc was performed using direct labeling method. To obtain optimum conditions, the experiment was carried out by varying some parameters such as the amount of reducing agent (SnCl2), ligand, pH reaction, and time of reaction. Each step of the reaction only one parameter varied while the other parameters are fixed. TcO4 with an activity of 1-3 mCi was put into the vial. The final volume for all experiments was carried out into 1 mL and incubation at room temperature was done with varying time reaction for 0, 15, 30, 45, and 60 minutes.
Determination of Radiochemical Yield of
99m Tc-Quercetin Radiochemical yield of 99m Tc-quercetin was determined using thin layer chromatography. To separate impurities To determine the distribution of radioactivity on chromatograms strips, every 1 cm segments of chromatograms strips were cut and measured using Single Channel Analyzer (SCA) with detector NaI(Tl).
RESULTS AND DISCUSSION
Quercetin is a yellow crystalline solid which is insoluble in water, therefore in this study quercetin was dissolved in ethanol absolute. As well as quercetin, SnCl2 is metal salts that are not soluble in aqueous. SnCl2 could be dissolved in water if the pH is quite low. Therefore in this study, preparation of SnCl2 solution was using HCl 0.1 N to maintain the low pH solution. When SnCl2 dissolved in HCl, a coordination complex of tin-chlorohexacoordinate was formed during the desolvation of SnCl2 in HCl, and the tin kept soluble by the complex 33 . In every experiment, SnCl2 solutions were freshly prepared and purged with nitrogen for 10 minutes. Four parameters which influence the labeling process have been varied to find optimum labeling condition. The first studied parameter was the amount of the reducing agent. SnCl2 as reducing agent will decrease the oxidation number of Tc-complex with high yield and purity was only formed when 99m Tc in the lower oxidation state. The result of the variation in the reducing agent showed in Fig. 3 , the highest radiochemical purity (RCP) was reached at 30 µg, this SnCl2 amount is equal to Sayed's experiment 28 . If the number of reducing agent is getting smaller or more than 30, it will decrease the RCP but not significantly different. Variation of reaction pH was carried out from acid to alkaline condition to determine the optimal reaction. The optimum pH needs to be determined because pH does not only affect solubility but also affects the rate of reaction. The RCP reach the highest values at the neutral condition (pH 7.5) as 91.29 % (Fig 4) . In this reaction phosphate buffer pH 7.5 was added to the stability of pH reaction and protected quercetin compounds from damage caused by alteration cause of pH. In acid condition, the solubility of the quercetin compound will decrease, while in alkaline condition may occur the degradation of quercetin compound 34 .
PREPARATION OF 99m Tc-QUERCETIN AS CANCER RADIOTRACER E. M. Widyasari et al. The optimal amount of quercetin in the labeling process was 500 µg with 93.20 ± 0.56 % of RCP ( Fig  5) . This result is similar to the optimum number of ligand from Sayed's experiment 28 . The optimal amount of quercetin must be determined to find the optimal concentration of ligand so the radiochemical impurities that occur due to deficiencies or excess ligand can be minimized. The optimum incubation time is reaction time that has the high RCP. Changing the temperature will affect the rate of a reaction, increase the temperature will increases the rate of reaction. But in this study incubation was done at room temperature, because quercetin is an antioxidant compound that is easy to be oxidized by heat. The optimum RCP was reaching right after adding 99m Tc to the mixture. The complexation process was rapid (Fig.-6) , only in 0 minutes the RCP was reached 98.52 ± 0.96 % and decreased continually until 97.36 % in 60 minutes incubation time. Tc-quercetin could be labeled high efficiency; hence this complex could be continued to in-vitro and in-vivo study to investigate the effectiveness of quercetin as an anticancer natural compound.
